Breast cancer is the most common form of cancer among women, and one of the most common types of cancers in general. Calculate that one in seven women alive at age 90 will develop breast cancer. It is particularly prevalent in some families, which make little diastrefomenes statistics. If you have a family history of breast cancer, the chances of your disease is much greater. That ’s therefore a good idea to stay very alert to detect breast cancer. the detection of breast cancer is initially difficult because the symptoms wear the notice ’section often themselves until the cancer is already in the later stages of growth, and may have already anaparachtei with metastases in other more vital areas of the body. This is why it is so important for women to get checked regularly. The mammography may be unpleasant, but the recent detection of breast cancer scenario is worse. The more common and detection of breast cancer is of course a piece of your chest. It is important to take into account that not all the pieces of cancer. Most women will develop the many pieces in their breasts throughout the course of their lives is particularly common during periods of rapid hormonal changes such as puberty and menstrual. Some women will have more tracks than others. A stricter detection of breast cancer will be pain in your breasts. A cancer that has grown large enough to hit on the nerves will be a axioprosechto on a single piece - a check or mammogram, so perhaps you ll arrest ‘anything before it gets to the point of causing pain. If one or both of the breasts you are in pain, again important to take account of worn ‘t necessarily have breast cancer. During puberty and periods of hormone flows, the tenderness of stithon is common. Also pregnancy, and some medicines can cause pain or tenderness in your breasts. Even though in most cases you detect breast cancer in women over 40, women in their teens and decades of the’20 also identified Read More This Post...
Factors such as age at menopause and breast-feeding practices may influence the risk for the development of certain types of breast cancer, according to the results of a study reported in the August 25 Online Publication issue of Cancer. “Molecular profiling studies have identified subtypes of breast cancer that can be approximately classified by estrogen receptor (ER), progesterone receptor (PR), and HER-2/neu (HER-2) [human epidermal growth factor receptor 2] expression,” write Amanda I. Phipps, MPH, from Fred Hutchinson Cancer Research Center in Seattle, Washington, and colleagues. “These molecular subtypes are prognostically significant, but to the authors’ knowledge, differences in their etiologic profiles have not been established. Reproductive factors may plausibly be differentially correlated with the risk of different breast cancer subtypes because these factors are presumed to impact exposure to endogenous sex hormones.” Pooled data from 2 population-based, case-control studies of breast cancer in women ages 55 to 79 years included 1476 control subjects and 1023 cases of patients with luminal breast cancer, 39 cases of patients with HER-2–overexpressing breast cancer, and 78 cases of patients with triple-negative breast cancer. To compare each case group with control subjects, the investigators used polytomous logistic regression. The associations varied based on molecular subtype. Early age at menarche was associated only with the risk for HER-2–overexpressing disease (odds ratio [OR], 2.7; 95% confidence interval [CI], 1.4 - 5.5). In contrast, breast-feeding for 6 months was protective only for luminal breast cancer (OR, 0.8; 95% CI, 0.6 - 1.0) and triple-negative disease (OR, 0.5; 95% CI, 0.3 - 0.9). Predictive factors of the risk for luminal disease were older age at menopause (OR, 1.6; 95% CI, 1.1 - 2.2) and use of estrogen plus progestin hormonal therapy (OR, 1.7; 95% CI, 1.3 - 2.1). There were no differences by Read More This Post...